|
Dr. Spangler is currently a Strategic Consultant of Investment Banking at The Keystone Equities Group. Dr. Spanglers primary focus is healthcare and biotechnology. Dr. Spangler received his B.S. and M.S. degrees in Molecular Biology and his Ph.D. in Physiology and Biophysics. He continued his education as a NIH postdoctoral scholar in the department of internal medicine at the University of Michigan. Following his postdoctoral training, Dr. Spangler joined the Procter and Gamble Company where he was responsible for their clinical research and development programs. After his tenure at Procter and Gamble, Dr. Spangler was Director of Worldwide Strategic Product Development for SmithKline Beecham Pharmaceuticals. Prior to joining The Keystone Equities Group, Dr. Spangler was General Partner of Coherent Capital Management, L.P. and Managing Director of Research for Emerging Growth Equities, Ltd. Dr. Spangler has authored more than 40 books and manuscripts covering a broad range of scientific disciplines. | 